20401 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines spiro-condensed
FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS
#2METHODS OF TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITOR DOSING FIELD OF THE INVENTION
#3TRICYCLIC SPIROLACTAM COMPOUNDS WITH ANTIMYCOBACTERIAL ACTIVITY
#4PHARMACEUTICAL COMPOSITIONS OF TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITOR AND METHODS FOR MAKING SAME
#5GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF
#63-BETA-HSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF
#7COMPOUNDS, COMPOSITIONS, AND METHODS
#8METHOD FOR TREATING PATIENT WITH BRCA-MUTATED CANCER
#9TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITORS
#10PHARMACEUTICAL COMPOSITIONS
#11TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITORS
#12COMPOUNDS, COMPOSITIONS AND METHODS
#13Spiros and Related Analogs for Inhibiting YAP/TAZ-TEAD
#14DIHYDRO-SPIRO[INDOLINE-3:1'-iSOQUINOLIN]-2-ONES AS ANTIMALARIAL AGENTS
#15Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
#16Tricyclic AKR1C3 dependent KARS inhibitors
#17KINASE INHIBITORS AND METHODS OF USE THEREOF
#18Optically active azabicyclo ring derivative
#19Kinase inhibitors and methods of use thereof
#20KINASE INHIBITORS AND METHODS OF USE THEREOF
#21Modulators of ATP-binding cassette transporters
#22USE AND COMPOSITION FOR TREATING DEMENTIA
#23Pharmacologically active compounds
#24Therapeutic compounds and uses thereof
#25USES OF PARALOG-SELECTIVE INHIBITORS OF GSK3 KINASES
#26Compounds inhibiting eukaryotic elongation factor 2 kinase activity
#27MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#28Pharmacologically active compounds
#29Liquid pharmaceutical formulations of palonosetron
#30Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4
#31Kinase inhibitors and methods of use thereof
#32Hematopoietic growth factor mimetic small molecule compounds and their uses
#33Modulators of ATP-binding cassette transporters
#34Pharmaceutical compounds
#35Use and composition for treating dementia
#36Compositions and methods for treating colon cancer
#37MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#38Compositions and methods of preventing or ameliorating abnormal thrombus formation and cardiovascular disease
#39Liquid pharmaceutical formulations of palonosetron
#40Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
#41Tetrahydroisoquinoline derivative
#42Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
#43Methods and compositions for inhibiting the nuclear factor κB pathway
#44Modulators of ATP-binding cassette transporters
#45Hematopoietic growth factor mimetic small molecule compounds and their uses
#46Spiroindoline modulators of muscarinic receptors
#47SHH Regulation and Methods Thereof
#48Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists
#49Cholinesterase Inhibitors for Treating Inflammation
#50Liquid pharmaceutical formulations of palonosetron
#51METHOD OF TREATING ILEUS BY PHARMACOLOGICAL ACTIVATION OF CHOLINERGIC RECEPTORS
#52Use and composition for treating dementia
#53Modulators of muscarinic receptors
#54Spiroindoline modulators of muscarinic receptors
#55Therapeutic compound and treatments
#56Modulators of ATP-binding cassette transporters
#57Modulators of ATP-binding cassette transporters
#58USE OF SIRAMESINE IN THE TREATMENT OF CANCER
#59Oral compositions containing a salivation inducing agent
#60Aminopyrrolidines as chemokine receptor antagonists
#61Heterocyclic antiviral compounds
#62Modulators of ATP-binding cassette transporters
#63Cholinesterase inhibitors for treating inflammation
#64Methods for treating sarcopenia with a growth hormone secretagogue
#65Method of treating ileus by pharmacological activation of cholinergic receptors
#66Methods of treating, preventing and inhibiting cancer metastasis and tumor formation
#67TREATMENT OF GLIAL TUMORS WITH GLUTAMATE ANTAGONISTS
#68Combination therapy for the treatment of diabetes
#69Piperidine derivatives
#70Oral compositions containing a salivation inducing agent
#71Growth hormone secretagogue receptor type 1A agonists
#72Dihydrospiroindene modulators of muscarinic receptors
#73Method of treating cancer with azaspirane compositions
#74Methods for relaxation of smooth muscle contractions using Trospium
#75Methods for treating urinary incontinence in patients suffering from memory disorders
#76Methods for treating smooth muscle disorders using trospium
#77Modulators of muscarinic receptors
#78Combination therapy for the treatment of obesity
#79Electrically variable pneumatic structural element
#80Interstitial cystitis treatment
#81Use of siramesine in the treatment of cancer
#82Liquid pharmaceutical formulations of palonosetron
#83Liquid pharmaceutical formulations of palonosetron
#84Combination therapy for the treatment of hypertension
#85Combination therapy for the treatment of dyslipidemia
#86FK228 analogs and methods of making and using the same
#87Spiroindoline modulators of muscarinic receptors
#88Modulators of ATP-binding cassette transporters
#89Liquid pharmaceutical formulations of palonosetron
#90Use of N-aryl diazaspiracyclic compounds in the treatment of addiction
#91Identification and use of growth hormone secretagogue receptor type 1A antagonists
#92Substituted pyridines having antiangiogenic activity
#93Therapeutic compound and treatments
#94Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
#95Combination therapy for the treatment of obesity
#96Neural tourniquet
#97Liquid pharmaceutical formulations containing 3.7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to arrhythmic events
#98Method of treating cancer with azaspirane compositions
#99Cholinesterase inhibitors for treating inflammation
#100Heterocyclic antiviral compounds
#101Pharmaceutical compositions
#102Method for treating circadian rhythm disruptions